Outlook Therapeutics OTLK
NASDAQ OTLK
$0.59 +0.02 (+3.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

Outlook Therapeutics (OTLK) Long-Term Investments (2020 - 2026)

Updated

Outlook Therapeutics' Long-Term Investments came in at $2.53 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 326.5% from $592,602 a year earlier and up 439.6% from the prior quarter.

Analysis

Outlook Therapeutics (OTLK) Long-Term Investments (2020 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Outlook Therapeutics' Long-Term Investments was $552,183, down 20.3% from FY2024.

  • Long-Term Investments has declined in each of the last five fiscal years, with a five-year compound annual growth rate of -9.3% (FY2020 to FY2025).
  • Going back by fiscal year, Long-Term Investments was $693,190 in FY2024 (-12.7%), $793,932 in FY2023 (-1.4%), $804,930 in FY2022 (-5.7%) and $853,660 in FY2021 (-5.1%).
  • The fiscal Q3 2026 figure represents the highest quarterly Long-Term Investments in data going back to fiscal Q4 2020.
  • Year-over-year, Long-Term Investments increased in 1 of the last eight quarters, with growth averaging 24.3%.
  • The fastest year-over-year change in Long-Term Investments over five years came in fiscal Q3 2026 (growth of 326.5%), and the weakest in fiscal Q2 2026 (a decline of 24.9%).
  • Business Quant data shows OTLK's Long-Term Investments at $468,430 (Q2 2026), $513,549 (Q1 2026) and $552,183 (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 266.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.62 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 1.56 Bn
10 Outlook Therapeutics 80.68 Mn 44.93 Mn -8,265.00 2.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.53 Mn
Mar 31, 2026 468,430.00
Dec 31, 2025 513,549.00
Sep 30, 2025 552,183.00
Jun 30, 2025 592,602.00
Mar 31, 2025 623,486.00
Dec 31, 2024 659,895.00
Sep 30, 2024 693,190.00
Jun 30, 2024 708,388.00
Mar 31, 2024 765,885.00
Dec 31, 2023 796,480.00
Sep 30, 2023 793,932.00
Jun 30, 2023 802,282.00
Mar 31, 2023 809,470.00
Dec 31, 2022 826,435.00
Sep 30, 2022 804,930.00
Jun 30, 2022 812,156.00
Mar 31, 2022 823,961.00
Dec 31, 2021 830,005.00
Sep 30, 2021 853,660.00
API Access

Outlook Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=OTLK&period=max&api_key=YOUR_API_KEY